Piper Sandler Cuts Upstart Target as Q1 Miss Tests Outlook
Piper Sandler trimmed its Upstart price target to $46 after a softer Q1 EBITDA print, but kept an Overweight rating a...
Understanding why personal financial planning is important can guide your financial decisions. Secure your future with effective planning.
24,448 articlesPiper Sandler trimmed its Upstart price target to $46 after a softer Q1 EBITDA print, but kept an Overweight rating a...
Super Micro Computer reports revenue that more than doubles year over year, yet the shares sit flat as questions abou...
Markets grapple with a hypothetical energy shock after a White House remark suggesting oil could surge to $200 per ba...
Investors speculate on Kevin Warsh becoming Fed chair, a move that could alter rate paths, liquidity and the long-run...
Palantir has wowed investors with AI-enabled results, but its sky-high valuation raises questions. This guide uses hi...
A thorough look at Novanta's Q1 2026 results and what they signal for novanta (novt) 2026 earnings. We break down rev...
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Investors are asking what the next five years hold for XRP. This guide breaks down plausible paths, key catalysts, ri...
XRP fell roughly 5% over the past seven days, pulling back from a short-lived bounce as traders weigh catalysts for a...
Microsoft posts solid Q3 results, showing AI and cloud momentum that investors say could unlock value in Big Tech. Th...
Deutsche Bank upgrades Humana to Buy with a near-doubling price target, as analysts anticipate a 2026 rebound in Medi...
Equities drift lower as oil prices jump, lifting energy shares and weighing on risk appetite. The S&P 500 retreats wh...